{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T22:14:15Z","timestamp":1778624055389,"version":"3.51.4"},"reference-count":29,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,3,20]],"date-time":"2026-03-20T00:00:00Z","timestamp":1773964800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003593","name":"Conselho Nacional de Desenvolvimento Cient\u00edfico e Tecnol\u00f3gico","doi-asserted-by":"publisher","award":["313668\/2023-0"],"award-info":[{"award-number":["313668\/2023-0"]}],"id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003593","name":"Conselho Nacional de Desenvolvimento Cient\u00edfico e Tecnol\u00f3gico","doi-asserted-by":"publisher","award":["402432\/2024-0"],"award-info":[{"award-number":["402432\/2024-0"]}],"id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003593","name":"Conselho Nacional de Desenvolvimento Cient\u00edfico e Tecnol\u00f3gico","doi-asserted-by":"publisher","award":["13179-PDPG"],"award-info":[{"award-number":["13179-PDPG"]}],"id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002322","name":"Coordena\u00e7\u00e3o de Aperfei\u00e7oamento de Pessoal de N\u00edvel Superior","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002322","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004263","name":"Funda\u00e7\u00e3o de Amparo \u00e0 Pesquisa do Estado do Rio Grande do Sul","doi-asserted-by":"publisher","award":["24\/2551-0001378-4"],"award-info":[{"award-number":["24\/2551-0001378-4"]}],"id":[{"id":"10.13039\/501100004263","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004263","name":"Funda\u00e7\u00e3o de Amparo \u00e0 Pesquisa do Estado do Rio Grande do Sul","doi-asserted-by":"publisher","award":["23\/2551-0001920-5"],"award-info":[{"award-number":["23\/2551-0001920-5"]}],"id":[{"id":"10.13039\/501100004263","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004263","name":"Funda\u00e7\u00e3o de Amparo \u00e0 Pesquisa do Estado do Rio Grande do Sul","doi-asserted-by":"publisher","award":["25\/2551-0001852-8"],"award-info":[{"award-number":["25\/2551-0001852-8"]}],"id":[{"id":"10.13039\/501100004263","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006734","name":"Instituto Nacional de Ci\u00eancia e Tecnologia de F\u00e1rmacos e Medicamentos","doi-asserted-by":"publisher","award":["402176\/2024-3"],"award-info":[{"award-number":["402176\/2024-3"]}],"id":[{"id":"10.13039\/501100006734","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Chromatography B"],"published-print":{"date-parts":[[2026,5]]},"DOI":"10.1016\/j.jchromb.2026.125026","type":"journal-article","created":{"date-parts":[[2026,3,13]],"date-time":"2026-03-13T16:38:41Z","timestamp":1773419921000},"page":"125026","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Bioanalytical HPLC\u2013DAD method for determining (E)-1-4(trifluoromethyl) benzylidene)-5-(2-4-dichlorozoyl) carbonylhydrazine (LASSBio-1736), a promising antileishmanial compound in canine plasma applied to pharmacokinetic studies"],"prefix":"10.1016","volume":"1276","author":[{"given":"Fl\u00e1via Elizabete Guerra","family":"Teixeira","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fernanda Melo","family":"de Oliveira","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Douglas Soares","family":"Inchauspe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L\u00eddia Moreira","family":"Lima","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sandra Elisa","family":"Haas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jchromb.2026.125026_bb0005","doi-asserted-by":"crossref","first-page":"2463","DOI":"10.1002\/vms3.1218","article-title":"Prevalence and incidence of canine visceral leishmaniasis and its clinical\u2013immunological features in an endemic area of the Brazilian Amazon","volume":"9","author":"Carneiro","year":"2023","journal-title":"Vet. Med. Sci."},{"key":"10.1016\/j.jchromb.2026.125026_bb0010","doi-asserted-by":"crossref","DOI":"10.1155\/japr\/8355886","article-title":"Performance of extracellular vesicles from Leishmania (Leishmania) infantum for serological diagnosis of human and canine visceral leishmaniasis","author":"da Cruz","year":"2025","journal-title":"J. Parasitol. Res."},{"key":"10.1016\/j.jchromb.2026.125026_bb0015","doi-asserted-by":"crossref","DOI":"10.1155\/2022\/5774296","article-title":"Canine Leishmaniasis in an Endemic Area for Human Leishmaniasis in Nicaragua","author":"Flores","year":"2022","journal-title":"J. Trop. Med."},{"key":"10.1016\/j.jchromb.2026.125026_bb0020","doi-asserted-by":"crossref","DOI":"10.1155\/2018\/3296893","article-title":"Canine leishmaniasis: an overview of the current status and strategies for control","author":"Ribeiro","year":"2018","journal-title":"Biomed. Res. Int."},{"key":"10.1016\/j.jchromb.2026.125026_bb0025","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1111\/tmi.12429","article-title":"Serological diagnosis of canine visceral leishmaniasis in Brazil: systematic review and meta-analysis","volume":"20","author":"Peixoto","year":"2015","journal-title":"Trop. Med. Int. Health"},{"key":"10.1016\/j.jchromb.2026.125026_bb0030","doi-asserted-by":"crossref","DOI":"10.1590\/s1984-29612024012","article-title":"Therapeutic success and failure in using miltefosine to treat dogs naturally infected with Leishmania infantum","volume":"33","author":"Gon\u00e7alves","year":"2024","journal-title":"Rev. Bras. Parasitol. Vet."},{"key":"10.1016\/j.jchromb.2026.125026_bb0035","series-title":"Leishmanioses: informe epidemiol\u00f3gico da Regi\u00e3o das Am\u00e9ricas. N\u00b0 13, dezembro de 2024","author":"Organiza\u00e7\u00e3o Pan-Americana da Sa\u00fade","year":"2024"},{"key":"10.1016\/j.jchromb.2026.125026_bb0040","doi-asserted-by":"crossref","DOI":"10.3390\/pathogens13060455","article-title":"Global distribution of canine visceral leishmaniasis and the role of the dog in the epidemiology of the disease","volume":"13","author":"Vilas-Boas","year":"2024","journal-title":"Pathogens"},{"key":"10.1016\/j.jchromb.2026.125026_bb0045","series-title":"Grupo de Estudos em Leishmaniose Animal, Diretrizes para o diagn\u00f3stico, estadiamento, tratamento e preven\u00e7\u00e3o da leishmaniose visceral canina no Brasil","author":"BRASILEISH","year":"2025"},{"key":"10.1016\/j.jchromb.2026.125026_bb0050","author":"Lima","year":"2013"},{"key":"10.1016\/j.jchromb.2026.125026_bb0055","doi-asserted-by":"crossref","first-page":"12384","DOI":"10.1039\/D0RA00287A","article-title":"Carbamoyl- N -aryl-imine-urea: a new framework to obtain a putative leishmanicidal drug-candidate","volume":"10","author":"Alves","year":"2020","journal-title":"RSC Adv."},{"key":"10.1016\/j.jchromb.2026.125026_bb0060","first-page":"1","article-title":"Leishmanicidal candidate LASSBio-1736, a cysteine protease inhibitor with favorable pharmacokinetics: low clearance and good distribution leishmanicidal candidate LASSBio-1736, a cysteine protease inhibitor with favorable pharmacokinetics: low clearan","volume":"0","author":"Moraes","year":"2017","journal-title":"Xenobiotica"},{"key":"10.1016\/j.jchromb.2026.125026_bb0065","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.4161\/mabs.32114","article-title":"Bioanalytical strategy used in development of pharmacokinetic (PK) methods that support biosimilar programs","volume":"6","author":"Colbert","year":"2014","journal-title":"MAbs"},{"key":"10.1016\/j.jchromb.2026.125026_bb0070","article-title":"Recent trends in microsampling and reduced-volume sample preparation procedures","volume":"14","author":"Perrucci","year":"2025","journal-title":"Adv. Sample Prep."},{"key":"10.1016\/j.jchromb.2026.125026_bb0075","doi-asserted-by":"crossref","DOI":"10.1016\/j.microc.2024.111903","article-title":"Recent trends in sampling and sorbent-based sample preparation procedures for bioanalytical applications","volume":"207","author":"Locatelli","year":"2024","journal-title":"Microchem. J."},{"key":"10.1016\/j.jchromb.2026.125026_bb0080","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1002\/bmc.3646","article-title":"Simple HPLC-UV for the quantification of a new leishmanicidal candidate (LASSBio-1736) in rat plasma for pharmacokinetics assessment","volume":"30","author":"Moraes","year":"2016","journal-title":"Biomed. Chromatogr"},{"key":"10.1016\/j.jchromb.2026.125026_bb0085","series-title":"ANVISA - Ag\u00eancia Nacional de Vigil\u00e2ncia Sanit\u00e1ria, Resolu\u00e7\u00e3o da Diretoria Colegiada - RDC n\u00b0 941, de 18 de novembro de 2024","year":"2024"},{"key":"10.1016\/j.jchromb.2026.125026_bb0090","article-title":"Click Analytical Chemistry Index as a novel concept and framework, supported with open source software to assess analytical methods","volume":"14","author":"Mansour","year":"2025","journal-title":"Adv. Sample Prep."},{"key":"10.1016\/j.jchromb.2026.125026_bb0095","article-title":"Analytical Green Star Area (AGSA) as a new tool to assess greenness of analytical methods","volume":"46","author":"Mansour","year":"2025","journal-title":"Sustain. Chem. Pharm."},{"key":"10.1016\/j.jchromb.2026.125026_bb0100","doi-asserted-by":"crossref","DOI":"10.1016\/j.microc.2026.116826","article-title":"Analytical method reliability index (AMRI) as an innovative tool and software for the assessment of analytical procedure","volume":"221","author":"Mansour","year":"2026","journal-title":"Microchem. J."},{"key":"10.1016\/j.jchromb.2026.125026_bb0105","doi-asserted-by":"crossref","first-page":"451","DOI":"10.3390\/analytica5030030","article-title":"Modified GAPI (MoGAPI) tool and software for the assessment of method greenness: case studies and applications","volume":"5","author":"Mansour","year":"2024","journal-title":"Analytica"},{"key":"10.1016\/j.jchromb.2026.125026_bb0110","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0269447","article-title":"Pre-clinical evaluation of LASSBio-1491: from in vitro pharmacokinetic study to in vivo leishmanicidal activity","volume":"17","author":"De Queiroz","year":"2022","journal-title":"PLoS One"},{"key":"10.1016\/j.jchromb.2026.125026_bb0115","doi-asserted-by":"crossref","DOI":"10.1002\/bmc.5519","article-title":"Bioanalytical methods for pharmacokinetic studies of antileishmanial drugs","volume":"37","author":"Roseboom","year":"2023","journal-title":"Biomed. Chromatogr."},{"key":"10.1016\/j.jchromb.2026.125026_bb0120","doi-asserted-by":"crossref","DOI":"10.1155\/2021\/3192960","article-title":"FML\/QuilA-vaccinated dogs naturally infected with Leishmania infantum: serum cytokines, clinicopathological profile, and parasitological parameters","volume":"2021","author":"Almeida","year":"2021","journal-title":"Biomed. Res. Int."},{"key":"10.1016\/j.jchromb.2026.125026_bb0125","article-title":"Clinical and parasitological impact of short-term treatment using miltefosine and allopurinol monotherapy or combination therapy in canine visceral leishmaniasis","volume":"31","author":"da C.B.S. Ayres","year":"2022","journal-title":"Rev. Bras. Parasitol. Vet."},{"key":"10.1016\/j.jchromb.2026.125026_bb0130","series-title":"U.S. Food and Drug Administration (FDA), Bioanalytical Method Validation Guidance for Industry","year":"2018"},{"key":"10.1016\/j.jchromb.2026.125026_bb0135","series-title":"ICH M10 on Bioanalytical Method Validation - Scientific Guideline","author":"International Concil Harmanisation","year":"2019"},{"key":"10.1016\/j.jchromb.2026.125026_bb0140","doi-asserted-by":"crossref","DOI":"10.1002\/jssc.202300571","article-title":"Matrix effects demystified: strategies for resolving challenges in analytical separations of complex samples","volume":"46","author":"Williams","year":"2023","journal-title":"J. Sep. Sci."},{"key":"10.1016\/j.jchromb.2026.125026_bb0145","article-title":"Green profile tools: current status and future perspectives","volume":"6","author":"Locatelli","year":"2023","journal-title":"Adv. Sample Prep."}],"container-title":["Journal of Chromatography B"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1570023226001157?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1570023226001157?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T21:20:32Z","timestamp":1778620832000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1570023226001157"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5]]},"references-count":29,"alternative-id":["S1570023226001157"],"URL":"https:\/\/doi.org\/10.1016\/j.jchromb.2026.125026","relation":{},"ISSN":["1570-0232"],"issn-type":[{"value":"1570-0232","type":"print"}],"subject":[],"published":{"date-parts":[[2026,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Bioanalytical HPLC\u2013DAD method for determining (E)-1-4(trifluoromethyl) benzylidene)-5-(2-4-dichlorozoyl) carbonylhydrazine (LASSBio-1736), a promising antileishmanial compound in canine plasma applied to pharmacokinetic studies","name":"articletitle","label":"Article Title"},{"value":"Journal of Chromatography B","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jchromb.2026.125026","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"125026"}}